Upexi, Inc. (NASDAQ:UPXI) Short Interest Update

Upexi, Inc. (NASDAQ:UPXI - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 299,500 shares, a growth of 30.3% from the May 15th total of 229,900 shares. Based on an average daily trading volume, of 2,290,000 shares, the short-interest ratio is presently 0.1 days. Approximately 1.0% of the shares of the company are short sold.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Cantor Fitzgerald upgraded shares of Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 target price for the company in a research report on Monday. Wall Street Zen upgraded shares of Upexi to a "hold" rating in a research note on Friday, May 30th.

Insider Buying and Selling

In other news, CEO Allan Marshall bought 657,895 shares of the firm's stock in a transaction on Thursday, April 17th. The stock was acquired at an average cost of $2.28 per share, with a total value of $1,500,000.60. Following the completion of the transaction, the chief executive officer now directly owns 809,318 shares of the company's stock, valued at $1,845,245.04. This represents a 434.47% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gene Salkind purchased 241,229 shares of the company's stock in a transaction dated Thursday, April 17th. The shares were purchased at an average cost of $2.28 per share, for a total transaction of $550,002.12. Following the transaction, the director now directly owns 365,127 shares in the company, valued at approximately $832,489.56. The trade was a 194.70% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 942,984 shares of company stock worth $2,150,004. Insiders own 31.60% of the company's stock.

Institutional Investors Weigh In On Upexi

A hedge fund recently bought a new stake in Upexi stock. Bank of Montreal Can acquired a new position in shares of Upexi, Inc. (NASDAQ:UPXI - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 10,008 shares of the company's stock, valued at approximately $36,000. Bank of Montreal Can owned about 0.81% of Upexi as of its most recent filing with the Securities and Exchange Commission. 5.68% of the stock is currently owned by institutional investors and hedge funds.

Upexi Stock Performance

Shares of Upexi stock traded up $0.48 during trading hours on Wednesday, reaching $10.07. The company had a trading volume of 96,085 shares, compared to its average volume of 879,059. Upexi has a one year low of $1.90 and a one year high of $22.57. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.37 and a quick ratio of 0.24. The business has a fifty day simple moving average of $9.80 and a 200 day simple moving average of $5.69.

Upexi (NASDAQ:UPXI - Get Free Report) last issued its earnings results on Friday, May 16th. The company reported ($2.87) EPS for the quarter. The company had revenue of $3.16 million during the quarter. Upexi had a negative return on equity of 535.19% and a negative net margin of 135.86%.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.